Literature DB >> 19409691

Testosterone therapy in castrate-resistant prostate cancer: a possible new approach.

Robert A Gardiner, Christopher Sweeney, Wayne D Tilley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19409691     DOI： 10.1016/j.eururo.2009.04.030

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.

Authors:  Yadong Xu; Qiong Song; Laura E Pascal; Mingming Zhong; Yibin Zhou; Jianhua Zhou; Fang-Ming Deng; Jiaoti Huang; Zhou Wang
Journal:  Prostate       Date:  2019-02-03       Impact factor: 4.104

2.  Nonmetastatic castration-resistant prostate cancer.

Authors:  Jun Hyuk Hong; Isaac Y Kim
Journal:  Korean J Urol       Date:  2014-03-13

Review 3.  Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.

Authors:  Osama S Mohammad; Michael D Nyquist; Michael T Schweizer; Stephen P Balk; Eva Corey; Stephen Plymate; Peter S Nelson; Elahe A Mostaghel
Journal:  Cancers (Basel)       Date:  2017-12-06       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.